Streetbeat News

Stock Prices

NABL

N-able, Inc. has reported its Q4 total revenue forecast to be between $106.5M and $107M, which falls short of the estimated $108.04M by analysts.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 12:04 pm

KMDA

Kamada (NASDAQ:KMDA) exceeded Q3 earnings and sales estimates, reporting EPS of $0.06, surpassing the $0.03 consensus, and sales of $37.93M, beating the $37.54M estimate. This reflects a significant increase from last year's figures, with a 500% rise in EPS and a 17.75% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 12:04 pm

AMPS

Altus Power (NYSE:AMPS) reported Q3 earnings of $0.03 per share, missing the consensus estimate of $0.08 by 62.5%. Sales were $45.08M, also below the expected $52.11M. Despite the miss, this reflects a significant improvement over the previous year, with a 104.76% increase in earnings and a 48.10% increase in sales compared to the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 12:03 pm

ROIV

Roivant Sciences (NASDAQ:ROIV) reported a narrower Q2 loss of $(0.40) per share compared to $(0.42) last year, and sales of $37.10M, surpassing the $29.39M estimate, marking a 196.05% increase from $12.53M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 12:02 pm

EDBL

Edible Garden AG (NASDAQ:EDBL) reported a significant reduction in its quarterly losses to $(0.69) per share from $(7.20) per share year-over-year. Additionally, the company's quarterly sales of $3.29 million exceeded the analyst consensus estimate of $3.07 million by 7.13% and marked a 19.43% increase from the previous year's sales of $2.75 million.

Portfolio Pulse from bharat@benzinga.com

November 13, 2023 | 12:02 pm

MNDY

Monday.Com (NASDAQ:MNDY) exceeded Q3 earnings and sales estimates, with an adjusted EPS of $0.64 surpassing the $0.20 estimate and sales of $189.19M beating the $182.36M estimate. This represents a significant increase from the same period last year, with earnings up 1180% and sales up 38.20%.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 12:01 pm

CPLP

Capital Product Partners (CPLP) reported Q3 adjusted EPS of $0.84, surpassing the $0.74 estimate, marking a 47.37% increase from the previous year. Sales reached $95.53M, exceeding the $88.24M estimate, up 32.94% from last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 12:01 pm

MIST

Milestone Pharmaceuticals (NASDAQ:MIST) reported Q3 earnings with an EPS of $-0.35, beating estimates by 7.89% but with a revenue decrease of $1.50 million from the previous year. Last quarter's EPS beat resulted in a 3.94% share price drop the following day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 12:00 pm

MIST

Milestone Pharmaceuticals (NASDAQ:MIST) reported a Q3 EPS loss of $(0.35), surpassing the consensus estimate of $(0.38) by 7.89%. The loss represents a slight increase from the $(0.34) per share loss in the same quarter last year. The company's cash reserves of $75.7M are expected to fund operations into mid-2025.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:59 am

TTI

XOM

Exxon Mobil Corp (XOM) plans to start lithium production in Arkansas by 2026, aiming to produce at least 10,000 metric tons annually in partnership with Tetra Technologies Inc (TTI). This move into the electric vehicle (EV) battery metal sector involves filtering lithium from brine deposits. XOM has also secured over 6,100 lithium-rich acres in Arkansas with TTI and plans additional production from another 100,000 acres by 2027. XOM's Q3 FY23 adjusted net profit was $9.12 billion, down from the previous year. XOM shares saw a slight premarket increase.

Portfolio Pulse from Lekha Gupta

November 13, 2023 | 11:41 am